Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jun 21, 2023

SELL
$135.66 - $197.02 $2,034 - $2,955
-15 Reduced 0.87%
1,700 $261,000
Q4 2021

Feb 02, 2022

SELL
$225.82 - $368.51 $45,164 - $73,702
-200 Reduced 10.44%
1,715 $436,000
Q2 2021

Aug 09, 2021

BUY
$129.91 - $234.98 $1,948 - $3,524
15 Added 0.79%
1,915 $802,000
Q1 2021

May 17, 2021

BUY
$109.18 - $185.98 $207,442 - $353,362
1,900 New
1,900 $285,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Gries Financial LLC Portfolio

Follow Gries Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gries Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gries Financial LLC with notifications on news.